These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20977456)

  • 1. Participation of CYP2C8 and CYP3A4 in the N-demethylation of imatinib in human hepatic microsomes.
    Nebot N; Crettol S; d'Esposito F; Tattam B; Hibbs DE; Murray M
    Br J Pharmacol; 2010 Nov; 161(5):1059-69. PubMed ID: 20977456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoinhibition of CYP3A4 leads to important role of CYP2C8 in imatinib metabolism: variability in CYP2C8 activity may alter plasma concentrations and response.
    Filppula AM; Neuvonen M; Laitila J; Neuvonen PJ; Backman JT
    Drug Metab Dispos; 2013 Jan; 41(1):50-9. PubMed ID: 23028140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent mechanism-based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates.
    Filppula AM; Laitila J; Neuvonen PJ; Backman JT
    Br J Pharmacol; 2012 Apr; 165(8):2787-98. PubMed ID: 22014153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.
    Illingworth NA; Boddy AV; Daly AK; Veal GJ
    Br J Pharmacol; 2011 Feb; 162(4):989-99. PubMed ID: 21054342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes.
    Nadin L; Murray M
    Biochem Pharmacol; 1999 Oct; 58(7):1201-8. PubMed ID: 10484078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib.
    Khan MS; Barratt DT; Somogyi AA
    Xenobiotica; 2016; 46(3):278-87. PubMed ID: 26161459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of hepatic cirrhosis on the intrinsic clearances of sorafenib and imatinib by CYPs in human liver.
    Murray M; Gillani TB; Ghassabian S; Edwards RJ; Rawling T
    Eur J Pharm Sci; 2018 Mar; 114():55-63. PubMed ID: 29223619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes.
    Kim KA; Park JY; Lee JS; Lim S
    Arch Pharm Res; 2003 Aug; 26(8):631-7. PubMed ID: 12967198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereo-selective metabolism of methadone by human liver microsomes and cDNA-expressed cytochrome P450s: a reconciliation.
    Chang Y; Fang WB; Lin SN; Moody DE
    Basic Clin Pharmacol Toxicol; 2011 Jan; 108(1):55-62. PubMed ID: 20825389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CYP3A4 and CYP2C8 as the major cytochrome P450 s responsible for morphine N-demethylation in human liver microsomes.
    Projean D; Morin PE; Tu TM; Ducharme J
    Xenobiotica; 2003 Aug; 33(8):841-54. PubMed ID: 12936704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxychloroquine is Metabolized by Cytochrome P450 2D6, 3A4, and 2C8, and Inhibits Cytochrome P450 2D6, while its Metabolites also Inhibit Cytochrome P450 3A
    Paludetto MN; Kurkela M; Kahma H; Backman JT; Niemi M; Filppula AM
    Drug Metab Dispos; 2023 Mar; 51(3):293-305. PubMed ID: 36446607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation.
    Projean D; Baune B; Farinotti R; Flinois JP; Beaune P; Taburet AM; Ducharme J
    Drug Metab Dispos; 2003 Jun; 31(6):748-54. PubMed ID: 12756207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation that cytochrome P450 2C8 (CYP2C8) plays a minor role in (S)-(+)- and (R)-(-)-ibuprofen hydroxylation in vitro.
    Chang SY; Li W; Traeger SC; Wang B; Cui D; Zhang H; Wen B; Rodrigues AD
    Drug Metab Dispos; 2008 Dec; 36(12):2513-22. PubMed ID: 18787056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of astaxanthin, β-cryptoxanthin, canthaxanthin, lutein, and zeaxanthin on cytochrome P450 enzyme activities.
    Zheng YF; Bae SH; Kwon MJ; Park JB; Choi HD; Shin WG; Bae SK
    Food Chem Toxicol; 2013 Sep; 59():78-85. PubMed ID: 23669408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
    Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
    Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of CYP3A4 in human hepatic diltiazem N-demethylation: inhibition of CYP3A4 activity by oxidized diltiazem metabolites.
    Sutton D; Butler AM; Nadin L; Murray M
    J Pharmacol Exp Ther; 1997 Jul; 282(1):294-300. PubMed ID: 9223567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathway-dependent inhibition of paclitaxel hydroxylation by kinase inhibitors and assessment of drug-drug interaction potentials.
    Wang Y; Wang M; Qi H; Pan P; Hou T; Li J; He G; Zhang H
    Drug Metab Dispos; 2014 Apr; 42(4):782-95. PubMed ID: 24476576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Halofantrine metabolism in microsomes in man: major role of CYP 3A4 and CYP 3A5.
    Baune B; Flinois JP; Furlan V; Gimenez F; Taburet AM; Becquemont L; Farinotti R
    J Pharm Pharmacol; 1999 Apr; 51(4):419-26. PubMed ID: 10385214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidation of troglitazone to a quinone-type metabolite catalyzed by cytochrome P-450 2C8 and P-450 3A4 in human liver microsomes.
    Yamazaki H; Shibata A; Suzuki M; Nakajima M; Shimada N; Guengerich FP; Yokoi T
    Drug Metab Dispos; 1999 Nov; 27(11):1260-6. PubMed ID: 10534310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.